HB326: HB326 State Health Benefit Plan Nonopioid Coverage Parity Act; enact
2025-2026 Regular Session · Comm Sub version · Last action February 24, 2026
26 LC 46 1473S
The House Committee on Health offers the following substitute to HB 326:
A BILL TO BE ENTITLED
AN ACT
To amend Article 1 of Chapter 18 of Title 45 of the Official Co de of Georgia Annotated,1
relating to state employees' health insurance plan and post-employment health benefit fund,2
so as to mandate that the state health benefit plan provide coverage for qualifying nonopioid3
pain management drugs in parity with its coverage for opioid pa in management drugs; to4
provide for definitions; to provide for parity with regard to annual deductibles, coinsurance,5
copayments, exclusions, reductions, other limitations, or utili zation review; to provide for6
legislative construction; to provide for related matters; to provide for a short title; to provide7
for legislative findings and declarations; to provide for an effective date; to repeal conflicting8
laws; and for other purposes.9
BE IT ENACTED BY THE GENERAL ASSEMBLY OF GEORGIA:10
SECTION 1.11
This Act shall be known and may be cited as the "State Health B enefit Plan Nonopioid12
Coverage Parity Act."13
SECTION 2.14
The General Assembly finds and declares that:15
H. B. 326 (SUB)
- 1 -
26 LC 46 1473S
(1) An opioid epidemic has cost the state millions of dollars in medical treatment, lost16
economic productivity, and increased overdose deaths, among other costs; and17
(2) Requiring coverage for nonopioid pain management drugs in the state health benefit18
plan that is at least as good as its coverage for opioid pain management drugs will reduce19
the costs borne by this state. 20
SECTION 3.21
Article 1 of Chapter 18 of Title 45 of the Official Code of Geo rgia Annotated, relating to22
state employees' health insurance plan and post-employment health benefit fund, is amended23
by adding a new Code section to read as follows:24
"45-18-4.3.25
(a) As used in this Code section, the term:26
(1) 'Healthcare provider' means the pharmacy, attending physician, or any other person27
or entity administering healthcare to a member of the state health benefit plan at the time28
of reference that is licensed, certified, or otherwise authoriz ed or permitted by law to29
administer healthcare in the ordinary course of business or pra ctice of a profession,30
including any person employed by or acting for any such authorized person or entity.31
(2) 'Prior authorization' means any requirement for the health care provider to obtain32
approval from the state health benefit plan prior to the furnishing of a drug.33
(3) 'Qualifying nonopioid pain management drugs' means a drug or biological product34
that:35
(A) Has a label indication approved by the federal Food and Drug Administration to36
reduce postoperative pain or any other form of acute pain;37
(B) Does not act upon the body's opioid receptors;38
(C) Is not a Schedule I or II controlled substance;39
(D) Has been selected by the Department of Community Health fo r inclusion in its40
formulary; and41
H. B. 326 (SUB)
- 2 -
26 LC 46 1473S
(E) Is sold or marketed in the United States.42
(4) 'State health benefit plan' means the health insurance plan established pursuant to this43
article.44
(5) 'Step therapy' means a drug therapy utilization management protocol or program that45
requires use of an alternative, preferred prescription drug or drugs before the state health46
benefit plan approves coverage for the nonpreferred drug therapy prescribed.47
(b) The state health benefit plan shall cover qualifying nonopioid pain management drugs48
and such drugs shall be subject to the same annual deductible, coinsurance, copayment,49
exclusions, reductions, or other limitations as to coverage, or utilization review applicable50
to similar covered opioid pain management drugs.51
(c) Notwithstanding subsection (b) of this Code section, nothing in this Code section shall52
be construed to prohibit the state health benefit plan from contracting to provide qualifying53
nonopioid pain management drug coverage for the state health benefit plan that is greater54
than the coverage provided for opioid pain management drugs.55
( d ) T h e s t a t e h e a l t h b e n e f i t p l a n s h a l l , w i t h r e s p e c t t o a q u alifying nonopioid pain56
management drug for which coverage is provided under such plan, neither impose any step57
therapy requirement under which an individual enrolled under such plan is required to use58
an opioid pain management drug prior to receiving the prescribe d qualifying nonopioid59
pain management drug nor require prior authorization for qualif ying nonopioid pain60
management drugs unless similar prior authorization is required for opioid pain61
management drugs.62
(e) Nothing in this Code section should be construed to interf ere with the ability of a63
healthcare provider to prescribe or administer a course of trea tment that is medically64
appropriate."65
SECTION 4.66
This Act shall become effective on January 1, 2027.67
H. B. 326 (SUB)
- 3 -
26 LC 46 1473S
SECTION 5.68
All laws and parts of laws in conflict with this Act are repealed.69
H. B. 326 (SUB)
- 4 -